Analyst Ratings for Kalvista Pharmaceuticals Inc (KALV)
KALV Rating Summary
KALV Price Target Summary
- Highest: $39.00 (Stifel)
- Lowest: $20.00 (Leerink Partners)
- Average: $33.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$33.50 (+106.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/31/2025 | Citizens » Updated 1/9/2026 |
Jonathan Wolleben | New Coverage | Market Outperform (N/A) |
29.00 (28.00) |
8.77 (16.23) |
85.06% | Details |
| 1/7/2025 | TD Cowen » Updated 1/29/2026 |
Stacy Ku | New Coverage | Buy (N/A) |
35.00 (30.00) |
8.68 (16.23) |
86.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
